Blind Intubation Through the Tulip Airway Versus Direct Laryngoscopy
Comparison of Blind Endotracheal Intubation Through the Tulip Oropharyngeal Airway and Direct Laryngoscopy by Novice Operators: A Randomized Crossover Manikin Study
1 other identifier
interventional
60
1 country
1
Brief Summary
This is a randomized crossover mannequin study comparing two airway management techniques in novice operators: blind endotracheal intubation via the Tulip oropharyngeal airway versus direct laryngoscopy. The study aims to evaluate and compare the success rate and performance characteristics of both methods under simulated conditions in order to assess their effectiveness in airway management training and practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 23, 2026
CompletedFirst Posted
Study publicly available on registry
July 2, 2026
CompletedStudy Start
First participant enrolled
July 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 10, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 10, 2026
July 13, 2026
July 1, 2026
1 month
June 23, 2026
July 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
First-pass intubation success rate
Comparison of first-attempt success rate of endotracheal intubation using Tulip oropharyngeal airway versus direct laryngoscopy in a simulated mannequin setting performed by novice operators in a randomized crossover design.
At each endotracheal intubation attempt during the single-day randomized crossover simulation session in a mannequin model
Study Arms (2)
Tulip Airway
ACTIVE COMPARATORBlind endotracheal intubation via Tulip oropharyngeal airway in a simulated mannequin environment.
Direct Laryngoscopy
ACTIVE COMPARATOREndotracheal intubation using standard direct laryngoscopy in a simulated mannequin environment.
Interventions
Endotracheal intubation via Tulip airway in a simulated mannequin setting.
Standard endotracheal intubation using direct laryngoscopy.
Eligibility Criteria
You may qualify if:
- Voluntary participation in the study
- Anesthesia technician students with no prior airway management experience
- Age ≥ 18 years
- Willingness to participate in simulation-based intubation procedures
You may not qualify if:
- Prior advanced airway management experience (e.g., regular intubation practice in clinical settings)
- Refusal to participate or withdraw consent
- Inability to complete simulation procedures for any reason
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Etlik City Hospital, Ministry of Health, Türkiye
Ankara, 06170, Turkey (Türkiye)
Study Officials
- PRINCIPAL INVESTIGATOR
Fethi Gültop, MD
Ankara Etlik City Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- No masking is used in this study. Both participants and investigators are aware of the intervention being performed, and outcome assessment is conducted in an open-label manner during a simulation-based setting.
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 23, 2026
First Posted
July 2, 2026
Study Start
July 6, 2026
Primary Completion (Estimated)
August 10, 2026
Study Completion (Estimated)
August 10, 2026
Last Updated
July 13, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
This is a simulation-based study using mannequin models; therefore, individual participant-level clinical data are not applicable and will not be shared.